Pfizer begins trial of COVID drug Paxlovid in kids 6 to 17
Novel radioligand therapy proven superior for metastatic prostate cancer patients
9 March 2022Scientists identify possible new treatment for COVID-19
9 March 2022Pfizer begins trial of COVID drug Paxlovid in kids 6 to 17
Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.
